This website will close on 30 April 2024. After this date, your content will not be accessible. Please contact for more information.

Proven innovation
Share innovation


By Sarah Fisher, Vinehealth Added 6th Sep, 2022 Updated 14th Sep, 2022

Vinehealth’s platform aims to improve the quality of life and outcomes of cancer patients. Co-developed with hundreds of patients and NHS oncologists, the platform combines behavioural science and AI to empower patients to self-manage effectively, through personalised Trust-specific information, remote support and communication with their care team.


The Vinehealth app generates rich longitudinal symptom and PROMS data to inform better clinical decision-making and efficient service delivery. There is strong evidence that this support and PROMS data improves the patient experience, improves clinical outcomes and reduces burden on clinicians and services.

Vinehealth is a CE-marked Class I medical device, have a 93% ORCHA rating and are compliant with all relevant NDA regulatory standards, including GDPR, DSPT, Cyber Essentials and DTAC. The solution has been iterated through >20,000 patient downloads and generated clinical evidence through service evaluations with leading NHS Trusts including The Royal Marsden and UCLH. Vinehealth is now looking for additional NHS partners to roll-out and conduct real-world evaluations of the technology.

Related Innovations